Icon

TRILIPIX (nda022224)- (EQ 45MG FENOFIBRIC ACID,EQ 135MG FENOFIBRIC ACID)

CHOLINE FENOFIBRATE ABBVIE
EQ 45MG FENOFIBRIC ACID,EQ 135MG FENOFIBRIC ACID
Yes Yes
2025-Jan-07 Expired
None 2011-Dec-15
None No
Trilipix is a peroxisome proliferator-activated receptor (PPAR) alpha agonist indicated as adjunctive therapy to diet to: • Reduce TG in patients with severe hypertriglyceridemia. • Reduce elevated LDL-C, Total-C, TG and Apo B, and to increase HDL-C in patients with primary hypercholesterolemia or mixed dyslipidemia
11 0 9
Total Other Developers 5
Drugs with Suitability No
EQ 45MG FENOFIBRIC ACID ** ** - - 5
EQ 135MG FENOFIBRIC ACID ** ** - - 5
NDA Sales Available Total Generic Sales Available
Yes 7
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** **** *** ****** *************** ******* ******* *********** ****** **.***, *** ** ***, **** ***** ********* *******-***** *******, ******* ******, *** *****, *********, ******* ******, ***** (***) ***
****** ********* ** ***** ******* *********** **** **. **-*, ***** *-*, ***** ********** ****, *****, ********, *** ******, ***** (***) ***
****** ******* ******* *************** ******* *********** *********** ********, ******* *******, *.*. *******, **** *****, ****** *****,, **********, ******* ******, ***** (***) ***
****** *** ****** *** ***************, ***. ******* ***** *********** *-*, ******* *** **., ******* ****, ******, ****** (***) ***
****** *** ****** *** ***************, ***. ******* ***** ******** ** *********** **, ******** **.,, ******* ****, ******, ****** (***) ***
****** ****** ******* *************** ******* ******* *********** ****** **. ***/* & ***/**, ******* *******, ********** ******, **********, ********* ******, ***** (***) ***
****** ******* ********* ******* ********* **** ***** ****** ***** *********** **. ***, ******* ****, *******, ***** ******, ***** (***) ***
****** ********* ****** *** ********* ****** ******* *********** ****-***, ** **. ***/*, ***/*, ***/*, ***/* & ***/*, **** ** **** ***, *****, ***** ********** ****, *********, ********* ******, ************, ********* ******, ***** (***) ***
****** ***** **** ***** **** ******* *********** **** **. *-*** ** *-*** & **, ***** *** & ***** **, ***** ********** ******, *****, *** ******, ***** (***) ***
****** ******** ****** *** ******** *************** ******* *********** ******* *****, **** ****** **********,****** *****, ******** *****, ******** ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.